Eduardo Bruno Martins

Insider Reports History

Entity
Individual
Location
350 Cambridge Ave, Suite 350, Palo Alto, CA
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eduardo Bruno Martins:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Chief Medical Officer Series A Common Stock 115K $365K $3.17 Feb 6, 2025 Direct
Sagimet Biosciences Inc. Chief Medical Officer Stock Option (Right to Buy) 138K Feb 6, 2025 Direct

Insider Reports Filed by Eduardo Bruno Martins

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMT Sagimet Biosciences Inc. Feb 6, 2025 2 $0 4 Feb 7, 2025 Chief Medical Officer
SGMT Sagimet Biosciences Inc. Jul 19, 2024 1 -$25.9K 4 Jul 23, 2024 Chief Medical Officer
SGMT Sagimet Biosciences Inc. Nov 17, 2023 1 $0 4 Nov 21, 2023 Chief Medical Officer
SGMT Sagimet Biosciences Inc. Jul 18, 2023 4 $0 4 Jul 20, 2023 Chief Medical Officer
SGMT Sagimet Biosciences Inc. Jul 13, 2023 0 $0 3 Jul 13, 2023 Director